Tivic Health Systems, Inc.
TIVC
$2.09
-$0.58-21.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.87% | -38.57% | -79.04% | -49.58% | -55.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.87% | -38.57% | -79.04% | -49.58% | -55.32% |
| Cost of Revenue | 254.88% | -70.91% | -88.02% | 19.03% | -52.87% |
| Gross Profit | -429.55% | 80.00% | -70.06% | -4,880.00% | -59.26% |
| SG&A Expenses | 40.55% | 34.10% | -12.28% | -48.60% | -31.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.85% | 43.67% | -13.17% | -33.76% | -23.75% |
| Operating Income | -73.52% | -52.76% | -1.69% | 31.24% | 18.69% |
| Income Before Tax | -81.41% | -52.53% | -1.42% | 34.15% | 18.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -81.41% | -52.53% | -1.42% | 34.15% | 18.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.41% | -52.53% | -1.42% | 34.15% | 18.69% |
| EBIT | -73.52% | -52.76% | -1.69% | 31.24% | 18.69% |
| EBITDA | -73.64% | -52.81% | -1.69% | 31.18% | 18.75% |
| EPS Basic | 49.09% | 59.16% | 85.32% | 87.64% | 84.37% |
| Normalized Basic EPS | 52.23% | 59.18% | 85.32% | 87.13% | 84.37% |
| EPS Diluted | 49.09% | 59.16% | 85.32% | 87.64% | 84.37% |
| Normalized Diluted EPS | 52.23% | 59.18% | 85.32% | 87.13% | 84.37% |
| Average Basic Shares Outstanding | 262.66% | 273.59% | 591.08% | 432.41% | 420.29% |
| Average Diluted Shares Outstanding | 262.66% | 273.59% | 591.08% | 432.41% | 420.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |